Sequential membrane- and protein-bound organelles compartmentalize genomes during phage infection
- PMID: 40168997
- PMCID: PMC12256282
- DOI: 10.1016/j.chom.2025.03.005
Sequential membrane- and protein-bound organelles compartmentalize genomes during phage infection
Abstract
Many eukaryotic viruses require membrane-bound compartments for replication, but no such organelles are known to be formed by prokaryotic viruses. Bacteriophages of the Chimalliviridae family sequester their genomes within a phage-generated organelle, the phage nucleus, which is enclosed by a lattice of the viral protein ChmA. We show that inhibiting phage nucleus formation arrests infections at an early stage in which the injected phage genome is enclosed within a membrane-bound early phage infection (EPI) vesicle. Early phage genes are expressed from the EPI vesicle, demonstrating its functionality as a prokaryotic, transcriptionally active, membrane-bound organelle. We also show that the phage nucleus is essential, with genome replication beginning after the injected DNA is transferred from the EPI vesicle to the phage nucleus. Our results show that Chimalliviridae require two sophisticated subcellular compartments of distinct compositions and functions that facilitate successive stages of the viral life cycle.
Keywords: EPI vesicle; bacterial cell biology; jumbo phage; phage; phage nucleus; viral organelle.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests K.P. and J.P. have an equity interest in Linnaeus Bioscience Incorporated and receive income. The terms of this arrangement have been reviewed and approved by the University of California, San Diego, in accordance with its conflict-of-interest policies. The regents of the University of California have patents issued and pending for CRISPR technologies on which J.A.D., B.F.C., B.A.A., D.F.S., E.C., J.P., K.P., E.G.A., and J.L. are inventors. J.A.D. is a cofounder of Azalea Therapeutics, Caribou Biosciences, Editas Medicine, Scribe Therapeutics, Intellia Therapeutics, and Mammoth Biosciences. J.A.D. is a scientific advisory board member of Vertex, Caribou Biosciences, Intellia Therapeutics, Scribe Therapeutics, Mammoth Biosciences, Algen Biotechnologies, Felix Biosciences, The Column Group, and Inari. J.A.D. is chief science advisor to Sixth Street; a director at Johnson & Johnson, Altos, and Tempus; and has research projects sponsored by Apple Tree Partners and Roche. D.F.S. is a cofounder and scientific advisory board member of Scribe Therapeutics.
References
-
- Taxonomy Browser International Committee on Taxonomy of Viruses (ICTV). https://ictv.global/taxonomy.
-
- Prichard A, Lee J, Laughlin TG, Lee A, Thomas KP, Sy AE, Spencer T, Asavavimol A, Cafferata A, Cameron M, et al. (2023). Identifying the core genome of the nucleus-forming bacteriophage family and characterization of Erwinia phage RAY. Cell Rep. 42, 112432. 10.1016/j.celrep.2023.112432. - DOI - PMC - PubMed
